2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$31.11+$0.14 (+0.45%)
Price as of Jun 23, 2026 4:37 PM EDT- $1.9BMarket Cap
- 167.21%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$31.11+$0.14 (+0.45%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.97 | ||
Change | -$0.03 (-0.10%) | ||
Open | $31.37 | ||
High | $31.61 | ||
Low | $30.91 | ||
Previous Close | $31.00 | ||
Volume | 617,217 | ||
30-Day Average Volume | 607,672 | ||
1-Week Change | 3.23% | ||
1-Month Change | 5.56% | ||
1-Year Change | 167.21% | ||
3-Year Change | 135.87% | ||
5-Year Change | -14.28% | ||
Fundamentals | |||
Shares Outstanding | 62.3M | ||
Total Assets | $443.3M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $6.2M | ||
Net Income | -$50.0M | ||
Free Cash Flow | -$60.9M | ||
EBIT | -$50.0M | ||
EBITDA | -$49.5M | ||
Net Working Capital | $325.9M | ||
EPS | -$0.79 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 285 | ||
P/B | 5 | ||
P/E | -39 | ||
PEG | -2 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue